PD ‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy-Reference-Cited by-同舟云学术

PD ‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy

Published:2016-12-08 Issue:2 Volume:9 Page:167-180
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Azad Abul¹,Yin Lim Su¹,D'Costa Zenobia¹,Jones Keaton¹,Diana Angela¹,Sansom Owen J²^ORCID,Kruger Philipp³,Liu Stanley⁴,McKenna W Gillies¹,Dushek Omer³^ORCID,Muschel Ruth J¹,Fokas Emmanouil¹^ORCID

Affiliation:

1. Department of Oncology CRUK/MRC Oxford Institute for Radiation Oncology University of Oxford Oxford UK

2. CRUK Beatson Cancer Institute University of Glasgow Glasgow UK

3. Sir William Dunn School of Pathology University of Oxford Oxford UK

4. Department of Radiation Oncology Sunnybrook Research Institute Sunnybrook Health Sciences Centre University of Toronto Toronto ON Canada

Funder

Cancer Research UK

Wellcome Trust

Royal Society

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201606674

Reference56 articles.

1. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions

2. Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages

3. Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression

4. PD‐1‐targeted immunotherapy: recent clinical findings;Brahmer JR;Clin Adv Hematol Oncol,2012

5. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pyroptosis-enhanced leucocyte-hitchhiking liposomal nanoplatform for potentiated immunotherapy of hepatocellular carcinoma;Materials Today Nano;2024-08

2. Mathematical modeling and analysis of cancer treatment with radiation and anti-PD-L1;Mathematical Biosciences;2024-08

3. Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review;Critical Reviews in Oncology/Hematology;2024-07

4. [18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response;Nuclear Medicine and Biology;2024-07

5. Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE);Japanese Journal of Clinical Oncology;2024-06-28